SoftBank Capital

About

Portfolio · 4

Chiasma

Oral Therapeutic Options for Patients with Rare Diseases

1 round $70.0M committed Latest: 2015-02

Taykey

Tracking Trending Content

3 rounds $30.0M committed Latest: 2015-01

ConteXtream

SDN Solutions and Network Function Virtualization

3 rounds $23.8M committed Latest: 2013-04

Insightix

Real-time Security Intelligence and Control Solutions

1 round $6.0M committed Latest: 2007-07

Investment activity

4 portfolio exits on record.

Q&A

What is SoftBank Capital's primary investment focus?

SoftBank Capital was the venture capital arm of SoftBank Group, investing in early-stage tech startups, particularly in internet, mobile, and software sectors. Its legacy continues through the SoftBank Vision Fund.

When was SoftBank Capital founded?

SoftBank Capital was founded in 1995.

Which notable companies were part of SoftBank Capital's portfolio?

SoftBank Capital backed notable companies such as Chiasma and Taykey.

Can you provide details on a recent exit for SoftBank Capital?

In November 2017, SoftBank Capital saw an exit with the acquisition of Taykey by Innovid.

What was a significant exit for SoftBank Capital in the health tech sector?

In July 2015, Chiasma, a SoftBank Capital portfolio company, had a Public Offering on NASDAQ with a valuation of $562M, raising $102M.

Which sectors has SoftBank Capital focused on for its portfolio companies?

SoftBank Capital's portfolio companies are primarily in Business Software, Cyber Security, and Health Tech & Life Sciences.

Who are the founders of SoftBank Capital?

Ron Fisher and Eric Hippeau are among the founders of SoftBank Capital.

What was SoftBank Capital's involvement with ConteXtream?

SoftBank Capital was an investor in ConteXtream, which was acquired by Micro Focus in May 2015.